Do I have a Celebrex Case?

FDA action on Tysabri
March 1, 2005 07:45

FDA MedWatch: Tysabri (natalizumab) marketing suspended due to serious adverse events reported with use

Vault Meloxicam (MOBIC) To Blockbuster Status. There is no medical reason why you should be taking meloxicam rather than an older, equally effective NSAID such as ibuprofen to manage arthritis.